Medpace 

$386.65
110
+$4.18+1.09% Friday 20:00

统计数据

当日最高
389.79
当日最低
380
52周最高
459.77
52周最低
227.21
成交量
194,208
平均成交量
373,979
市值
11.99B
市盈率
36.34
股息收益率
-
股息
-

即将到来

收益

21Oct已确认
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
1.8
2.27
2.73
3.2
预期每股收益
2.799967
实际每股收益
N/A

人们还关注

此列表基于关注MEDP的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

426.5$平均价格目标
最高估值为 $480。
来自过去6个月内的 9 个评级。这不是投资建议。
买入
78%
持有
22%
卖出
0%

关于

Commercial Services
Miscellaneous Commercial Services
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
首席执行官
August Troendle
员工
5800
国家
US
ISIN
US58506Q1094
WKN
000A2APTV

上市公司